88 results
NT 10-Q
AUTL
Autolus Therapeutics plc
13 May 24
Notice of late quarterly filing
9:33am
statements are reasonable, the Company can give no assurance that such expectations will prove to be correct. Readers are cautioned that actual results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The selling securityholder … expressed or implied by our forward-looking statements. As a result of these factors, there can be no assurance that the forward-looking statements
10-K
ob6i4
21 Mar 24
Annual report
4:55pm
10-K
EX-10.12
udfu663f0swjlx6mk7vv
21 Mar 24
Annual report
4:55pm
10-K
EX-31.2
wh3qc5um6
21 Mar 24
Annual report
4:55pm
10-K
EX-31.1
jvtag6s8x krd42zl
21 Mar 24
Annual report
4:55pm
424B5
tiwc6yfmc0wsolcx
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
h7ohm5
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-1.1
1a2ivclj
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
vybbp14c8d
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
EX-5.2
3mdabc90sf2g tvm
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
2sjyopkoo z29m0npdp
7 Feb 24
Automatic shelf registration
10:00pm
10-Q
iqi ma8lxqla7lhgjb
9 Nov 23
Quarterly report
4:18pm
10-Q
EX-31.2
48fv70 k4jfb
9 Nov 23
Quarterly report
4:18pm
10-Q
EX-31.1
b4fwtrei2e7oxlfi
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.1
8czt1
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1.1
fp1vp823nc
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm